Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Am J Obstet Gynecol. 2015 Aug 10;214(1):99.e1–99.e8. doi: 10.1016/j.ajog.2015.08.011

Figure 3.

Figure 3

Figure 3

Upper Panel. CD8+ and CD4+ T cell proliferation in the ascitic fluid of EpCAM + USC patients after incubation with control BiTE® vs solitomab. Lower panel. Graph showing the percentage of EpCAM positive viable cell in patients’ ascites after 5 days incubation with control BiTE® vs solitomab.